SC 13D/A

AMENDMENT NO. 1 TO SCHEDULE 13D

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filed: February 20, 2024
Accession Number: 0001213900-24-015393

View Document ↗ View on SEC.gov ↗